Cardiomyopathy

Chairs

Saro Armenian, City of Hope National Medical Center, Duarte, CA, United States
Leontien C.M. Kremer, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands and Emma Children’s Hospital, Amsterdam UMC, University of Amsterdam, the Netherlands

Coordinators

Matthew Ehrhardt, St. Jude Children’s Research Hospital, Memphis, United States
Jan M. Leerink, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands and Amsterdam UMC, University of Amsterdam, the Netherlands

Advisors

Renée L. Mulder, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Melissa M. Hudson, St. Jude Children’s Research Hospital, Memphis, United States
Roderick Skinner, Great North Children’s Hospital and Newcastle University Centre for Cancer, Newcastle upon Tyne, United Kingdom
W. Hamish Wallace, Royal Hospital for Sick Children, Edinburgh, United Kingdom
Louis S. Constine, University of Rochester Medical Center, Rochester, United States
Elizabeth A.M. Feijen, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Eric J. Chow, Seattle Children’s Hospital, University of Washington, Seattle, WA, USA and Fred Hutchinson Cancer Research Center, Seattle, United States

WG leaders

Paul C. Nathan, The Hospital for Sick Children, Toronto, Canada
Anju Nohria, Brigham and Women’s Hospital, Boston, United States
Annelies M.C. Mavinkurve-Groothuis, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Wouter E.M. Kok, Amsterdam UMC, University of Amsterdam, the Netherlands

WG members

Ogechukwu Asogwa, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Edit Bárdi, Kepler Universitätsklinikum, Linz, Austria and Semmelweis University, Budapest, Hungary
Ming Hui Chen, Boston Children’s Hospital/Dana Farber Cancer Institute, Boston, United States
Charlotte Demoor-Goldschmidt, Centre for Research in Epidemiology and Population Health, Cancer and Radiation team, University of Paris-Sud, Villejuif, France and CHU Angers, France
Esmee C. de Baat, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Maëlle de Ville de Goyet, Universitaires Saint-Luc, Brussels, Belgium and Institut de Recherche Expérimentale et Clinique, Brussels, Belgium
Brice Fresneau, Gustave Roussy, Villejuif, France
Heynric Grotenhuis, University Medical Center Utrecht, Utrecht, Netherlands
Nadia Haddy, Gustave Roussy, Villejuif, France and INSERM U1018, Paris-Sud XI University, Centre for Research in Epidemiology and Population Health, Cancer & Radiations Group, Gustave Roussy Cancer Campus, Villejuif, France
Ulrike Hennewig, University Hospital of Giessen and Marburg, Giessen, Germany
Gill Levitt, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom
Remy Merkx, Radboud University Medical Center, Nijmegen, the Netherlands
Vesna Pavasovic, Great Ormond Street Hospital, London, United Kingdom
Chris Plummer, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
Maya Prasad, Tata Memorial Hospital, Parel, Mumbai, India and Homi Bhabha National Institute, Mumbai, India
Julia Steinberger, University of Minnesota School of Medicine, Minneapolis, United States
Arco Teske, University Medical Center Utrecht, Utrecht, Netherlands
Elvira van Dalen, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Helena van der Pal, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands